Blue Biofuels

Blue Biofuels

Incorporated in 2006, Blue Biofuels operates as a technology and process engineering company focused on commercializing its proprietary Cellulose-to-Sugar (CTS) technology. CEO Ben Slager has guided the firm through multiple iterations of prototype development, with the core innovation being a mechano-chemical reactor that breaks down lignocellulosic biomass — grass, wood chips, agricultural waste — into fermentable sugars at ambient temperature and pressure. That contrasts sharply with the high-heat, high-pressure, enzyme-heavy processes that dominate second-generation ethanol research. The firm is publicly traded on the OTCQB market under the ticker BIOF. The CTS process targets feedstocks including king grass and sugarcane bagasse, both of which Slager has described as scalable inputs for Florida and the southeastern United States. The company holds a key patent (US Patent 11,186,510) covering the rotary reactor and its dilithium phosphate catalyst, which it licenses to project developers rather than operating production plants directly. Its stated deployment model involves licensing the reactor to biofuel producers or partnering with agricultural landowners to co-locate processing equipment near the feedstock source. In 2023 the firm announced a pilot production milestone — processing king grass grown on its own Florida acreage into sugars at a scale of approximately one ton per day, with the resulting sugars shipped to a third-party fermentation lab for ethanol conversion. Blue Biofuels' team is lean — the company does not disclose total headcount but files as a smaller reporting company with the SEC. Its public filings show no material revenue to date, consistent with a pre-revenue technology licensor. The firm has funded operations primarily through equity raises and convertible notes. Recent activity: April 2024 — the company signed a memorandum of understanding with a Florida-based energy cooperative to explore a commercial-scale king-grass-to-ethanol facility in Hendry County, representing its first explicit path toward a revenue-generating project. The company maintains a small research plot in Palm Beach County where it grows the biomass used in engineering trials. What structurally differentiates Blue Biofuels from most biofuel ventures is its focus on a single enabling piece of process hardware — a room-temperature reactor — rather than vertically integrated fuel production. That means its capital needs are modest compared to construction-heavy corn-ethanol plants, but its business model depends entirely on large-scale license adoption. The reactor's value proposition hinges on eliminating enzymes, which account for roughly a quarter of operating costs in traditional cellulosic ethanol plants. The company is vulnerable to the same feedstock procurement and logistics constraints that have stalled other cellulosic ventures, but its patent-centered, asset-light structure is unusual for the sector.